ArticleFrontiers in pharmacology2020

Weichang'an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer-Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1.

Chuan-Fang Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.